Energenesis Biomedical CO.,LTD. (6657.TW)

TWD 56.6

(-4.87%)

Net Debt Summary of Energenesis Biomedical CO.,LTD.

  • Energenesis Biomedical CO.,LTD.'s latest annual net debt in 2023 was -246.6 Million TWD , down -195.47% from previous year.
  • Energenesis Biomedical CO.,LTD.'s latest quarterly net debt in 2024 Q2 was -192.82 Million TWD , up 34.05% from previous quarter.
  • Energenesis Biomedical CO.,LTD. reported annual net debt of -80.66 Million TWD in 2022, up 41.31% from previous year.
  • Energenesis Biomedical CO.,LTD. reported annual net debt of -137.43 Million TWD in 2021, down -130.91% from previous year.
  • Energenesis Biomedical CO.,LTD. reported quarterly net debt of -292.37 Million TWD for 2024 Q1, down -18.56% from previous quarter.
  • Energenesis Biomedical CO.,LTD. reported quarterly net debt of -247.94 Million TWD for 2023 Q3, down -1.7% from previous quarter.

Annual Net Debt Chart of Energenesis Biomedical CO.,LTD. (2023 - 2019)

Historical Annual Net Debt of Energenesis Biomedical CO.,LTD. (2023 - 2019)

Year Net Debt Net Debt Growth
2023 -246.6 Million TWD -195.47%
2022 -80.66 Million TWD 41.31%
2021 -137.43 Million TWD -130.91%
2020 -59.51 Million TWD 38.58%
2019 -96.9 Million TWD 0.0%

Peer Net Debt Comparison of Energenesis Biomedical CO.,LTD.

Name Net Debt Net Debt Difference
Apex Biotechnology Corp. -201.21 Million TWD -22.559%
Sinphar Pharmaceutical Co.,Ltd. 870.53 Million TWD 128.328%
Panion & Bf Biotech Inc. 193.2 Million TWD 227.639%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 939.54 Million TWD 126.248%
GenMont Biotech Incorporation 2.71 Million TWD 9193.215%
Abnova (Taiwan) Corporation -415.8 Million TWD 40.692%
Adimmune Corporation 685.12 Million TWD 135.994%
Tanvex BioPharma, Inc. 1.35 Billion TWD 118.253%
Polaris Group -2.41 Billion TWD 89.805%
UnicoCell Biomed Co., Ltd. 54.43 Million TWD 553.074%
PELL Bio-Med Technology Co. Ltd. 4.88 Million TWD 5152.407%